Journal of Diagnostics Concepts & Practice››2021,Vol. 20››Issue (06): 592-595.doi:10.16150/j.1671-2870.2021.06.016
• Review articles •Previous ArticlesNext Articles
Received:2021-02-10Online:2021-12-25Published:2021-12-25| [1] | Weidinger S, Novak N. Atopic dermatitis[J]. Lancet, 2016, 387(10023):1109-1122. doi:S0140-6736(15)00149-Xpmid:26377142 |
| [2] | Meng Q, Liu X, Li P, et al. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis[J]. Int Forum Allergy Rhinol, 2016, 6(8):862-870. doi:10.1002/alr.21743URL |
| [3] | 龙玲珑, 姚煦, 杨雪源. 变应原特异性免疫治疗特应性皮炎的进展[J]. 国际皮肤性病学杂志, 2017, 43(2):65-68. |
| [4] | Furue M, Chiba T, Tsuji G, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies[J]. Allergol Int, 2017, 66(3):398-403. doi:10.1016/j.alit.2016.12.002URL |
| [5] | Takemura M, Nakahara T, Hashimoto-Hachiya A, et al. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis[J]. Int J Mol Sci, 2018, 19(4):1169. doi:10.3390/ijms19041169URL |
| [6] | Guttman-Yassky E, Nograles KE, Krueger JG. Contras-ting pathogenesis of atopic dermatitis and psoriasis--part Ⅱ: immune cell subsets and therapeutic concepts[J]. J Allergy Clin Immunol, 2011, 127(6):1420-1432. doi:10.1016/j.jaci.2011.01.054pmid:21419481 |
| [7] | Jaitley S, Saraswathi T. Pathophysiology of langerhans cells[J]. J Oral Maxillofac Pathol, 2012, 16(2):239-244. doi:10.4103/0973-029X.99077URL |
| [8] | 周杰, 陈曙光, 宋志强. 特异性免疫疗法治疗特应性皮炎[J]. 中华临床免疫和变态反应杂志, 2021, 15(1):76-81. |
| [9] | Huang FL, Liao EC, Yu SJ. House dust mite allergy: Its innate immune response and immunotherapy[J]. Immunobiology, 2018, 223(3):300-302. doi:10.1016/j.imbio.2017.10.035URL |
| [10] | 宋志强. 特应性皮炎的变应原特异性免疫治疗[J]. 中国医学文摘(皮肤科学), 2016, 33(2):180-183. |
| [11] | Yu SJ, Liao EC, Tsai JJ. Effects of local nasal immunotherapy in allergic airway inflammation: using urea denatured Dermatophagoides pteronyssinus[J]. Hum Vaccin Immunother, 2015, 11(4):915-921. doi:10.1080/21645515.2015.1012029URL |
| [12] | Fuiano N, Incorvaia C. Dissecting the causes of atopic dermatitis in children: less foods, more mites[J]. Allergol Int, 2012, 61(2):231-243. doi:10.2332/allergolint.11-RA-0371URL |
| [13] | Bumbacea RS, Corcea SL, Ali S, et al. Mite allergy and atopic dermatitis: Is there a clear link?(Review)[J]. Exp Ther Med, 2020, 20(4):3554-3560. doi:10.3892/etm.2020.9120pmid:32905207 |
| [14] | Kato T, Takai T, Fujimura T, et al. Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes[J]. Allergy, 2009, 64(9):1366-1374. doi:10.1111/j.1398-9995.2009.02023.xpmid:19416145 |
| [15] | Serhan N, Basso L, Sibilano R, et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation[J]. Nat Immunol, 2019, 20(11):1435-1443. doi:10.1038/s41590-019-0493-zURL |
| [16] | Miller JD. The Role of Dust Mites in Allergy[J]. Clin Rev Allergy Immunol, 2019, 57(3):312-329. doi:10.1007/s12016-018-8693-0URL |
| [17] | 黄迎, 钱秋芳, 张志红, 等. 1140例特应性皮炎患儿血清过敏原检测及分析[J]. 中国麻风皮肤病杂志, 2019, 35(11):689-691,700. |
| [18] | Kim J, Lee S, Woo SY, et al. The indoor level of house dust mite allergen is associated with severity of atopic dermatitis in children[J]. J Korean Med Sci, 2013, 28(1):74-79. doi:10.3346/jkms.2013.28.1.74URL |
| [19] | Cid BJ, Perez-Mateluna G, Iturriaga C, et al. Is there an association between indoor allergens and the severity of atopic dermatitis?[J]. Int J Dermatol, 2019, 58(4):433-439. doi:10.1111/ijd.14281URL |
| [20] | Wisniewski JA, Agrawal R, Minnicozzi S, et al. Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis[J]. Clin Exp Allergy, 2013, 43(10):1160-1170. doi:10.1111/cea.12169pmid:24074334 |
| [21] | Su KW, Chiu CY, Tsai MH, et al. Asymptomatic toddlers with house dust mite sensitization at risk of asthma and abnormal lung functions at age 7 years[J]. World Allergy Organ J, 2019, 12(9):100056. doi:10.1016/j.waojou.2019.100056URL |
| [22] | Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life[J]. J Allergy Clin Immunol, 2017, 139(2):541-549. doi:10.1016/j.jaci.2016.08.014URL |
| [23] | Bremmer SF, Simpson EL. Dust mite avoidance for the primary prevention of atopic dermatitis: A systematic review and meta-analysis[J]. Pediatr Allergy Immunol, 2015, 26(7):646-654. doi:10.1111/pai.12452URL |
| [24] | Bumbacea RS, Corcea SL, Ali S, et al. Mite allergy and atopic dermatitis: Is there a clear link?(Review)[J]. Exp Ther Med, 2020, 20(4):3554-3560. doi:10.3892/etm.2020.9120pmid:32905207 |
| [25] | Kanchongkittiphon W, Gaffin JM, Phipatanakul W. Child with atopic dermatitis[J]. Ann Allergy Asthma Immunol, 2015, 114(1):6-11. doi:10.1016/j.anai.2014.08.016URL |
| [26] | 宋志强, 郝飞. 特异性免疫治疗在特应性皮炎中的应用[J]. 中华临床免疫和变态反应杂志, 2008, 2(2):137-141. |
| [27] | Zhong H, Deng X, Song Z, et al. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite[J]. J Eur Acad Dermatol Venereol, 2015, 29(7):1318-1324. doi:10.1111/jdv.12813pmid:25376542 |
| [28] | Zhou J, Chen S, Song Z. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis[J]. Allergy Asthma Proc, 2021, 42(2):e47-e54. doi:10.2500/aap.2021.42.200126pmid:33685566 |
| [29] | Qin YE, Mao JR, Sang YC, et al. Clinical efficacy and compliance of sublingual immunotherapy with Dermatophagoides farinae drops in patients with atopic dermatitis[J]. Int J Dermatol, 2014, 53(5):650-655. doi:10.1111/ijd.12302URL |
| [30] | Liu L, Chen J, Xu J, et al. Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):3540-3547. doi:10.1080/21691401.2019.1640709URL |
| [31] | 彭戈, 韩秀萍. 特异性免疫治疗在特应性皮炎中的研究进展[J]. 临床皮肤科杂志, 2017, 46(8):69-71. |
| [32] | Fujita H, Soyka MB, Akdis M, et al. Mechanisms of allergen-specific immunotherapy[J]. Clin Transl Allergy, 2012, 2(1):2. doi:10.1186/2045-7022-2-2URL |
| [33] | Nahm DH, Kim ME, Kwon B, et al. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis[J]. Yonsei Med J, 2016, 57(6):1420-1426. doi:10.3349/ymj.2016.57.6.1420URL |
| [34] | Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis[J]. J Allergy Clin Immunol, 2012, 130(4):925-931. doi:10.1016/j.jaci.2012.08.004URL |
| [35] | Elazab SZ, Hessam WF, Gomaa AH. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite[J]. Egypt J Immunol, 2018, 25(2):97-106. |
| [36] | Choi JS, Ryu HR, Yoon CH, et al. Treatment of patients with refractory atopic dermatitis sensitized to house dust mites by using sublingual allergen immunotherapy[J]. Ann Dermatol, 2015, 27(1):82-86. doi:10.5021/ad.2015.27.1.82URL |
| [37] | Di Rienzo V, Cadario G, Grieco T, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study[J]. Ann Allergy Asthma Immunol, 2014, 113(6):671-673. doi:10.1016/j.anai.2014.09.009URL |
| [38] | You HS, Yang MY, Kim GW, et al. Effectiveness of specific sublingual immunotherapy in korean patients with atopic dermatitis[J]. Ann Dermatol, 2017, 29(1):1-5. doi:10.5021/ad.2017.29.1.1URL |
| [39] | Lee J, Lee H, Noh S, et al. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis[J]. Yonsei Med J, 2016, 57(2):393-398. doi:10.3349/ymj.2016.57.2.393URL |
| [40] | Bae JM, Choi YY, Park CO, et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials[J]. J Allergy Clin Immunol, 2013, 132(1):110-117. doi:10.1016/j.jaci.2013.02.044URL |
| [41] | Tam H, Calderon MA, Manikam L, et al. Specific allergen immunotherapy for the treatment of atopic eczema[J]. Cochrane Database Syst Rev, 2016, 2:CD008774. |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
